Detalhe da pesquisa
1.
Effective delivery of Complex Innovative Design (CID) cancer trials-A consensus statement.
Br J Cancer
; 122(4): 473-482, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31907370
2.
A phase I open-label dose-escalation study of the anti-HER3 monoclonal antibody LJM716 in patients with advanced squamous cell carcinoma of the esophagus or head and neck and HER2-overexpressing breast or gastric cancer.
BMC Cancer
; 17(1): 646, 2017 Sep 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-28899363